Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Decker

Showing results (261-270 of 296) with videos related to

Pageof 30
Sort By:
Cancer|March 22, 2017
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinomaYi An, Henry S Park, Jacqueline R Kelly, et al.
JAMA Oncology|October 14, 2016
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell CarcinomaZain A Husain, Tiange Chen, Christopher D Corso, et al.
The Journal of Infectious Diseases|January 1, 1988
Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteinsG J Dawson, J S Heller, C A Wood, et al.
Gynecologic Oncology|May 7, 2016
Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data BaseNataniel H Lester-Coll, Henry S Park, Charles E Rutter, et al.
American Journal of Clinical Oncology|September 28, 2011
ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancerRoy H Decker, Corey J Langer, Kenneth E Rosenzweig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trialMark A Socinski, Thomas E Stinchcombe, Dominic T Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer TumorsOlivia J Kelada, Roy H Decker, Sameer K Nath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2015
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerChristopher D Corso, Charles E Rutter, Henry S Park, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2018
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisBenjamin H Kann, Joseph A Miccio, John M Stahl, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patientsFrank C Detterbeck, Vincent J Mase, Andrew X Li, et al.
Pageof 30

Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
Cancer|March 22, 2017
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinomaYi An, Henry S Park, Jacqueline R Kelly, et al.
JAMA Oncology|October 14, 2016
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell CarcinomaZain A Husain, Tiange Chen, Christopher D Corso, et al.
The Journal of Infectious Diseases|January 1, 1988
Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteinsG J Dawson, J S Heller, C A Wood, et al.
Gynecologic Oncology|May 7, 2016
Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data BaseNataniel H Lester-Coll, Henry S Park, Charles E Rutter, et al.
American Journal of Clinical Oncology|September 28, 2011
ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancerRoy H Decker, Corey J Langer, Kenneth E Rosenzweig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trialMark A Socinski, Thomas E Stinchcombe, Dominic T Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer TumorsOlivia J Kelada, Roy H Decker, Sameer K Nath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2015
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerChristopher D Corso, Charles E Rutter, Henry S Park, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2018
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisBenjamin H Kann, Joseph A Miccio, John M Stahl, et al.
Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patientsFrank C Detterbeck, Vincent J Mase, Andrew X Li, et al.
Pageof 30